Institutional Ownership Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX). We have compiled data on the 70 institutions that hold shares in the stock, with a total of 50.4 Million shares, which have been reported (via 13F filing form) to have a value of $44.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
West Hill Financial Advisors, Inc.
|
Oct 18, 2024 Q3 2024 |
17,082
shares
|
$15,202
0.0% of portfolio
|
Q4 2020
New holding
|
|
|
Nierenberg Investment Management Company, Inc.
Camas, WA |
Nov 13, 2024 Q3 2024 |
12,555
shares
|
$11,173
0.01% of portfolio
|
Q2 2024
New holding
|
|
|
Ipg Investment Advisors LLC
San Diego, CA |
Nov 12, 2024 Q3 2024 |
12,500
shares
|
$11,125
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
12,000
shares
|
$10,680
0.0% of portfolio
|
Q3 2024
Reduced 89.02%
|
|
|
Ep Wealth Advisors, LLC
Torrance, CA |
Nov 14, 2024 Q3 2024 |
10,432
shares
|
$9,284
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
10,304
shares
|
$9,170
0.0% of portfolio
|
Q3 2024
Reduced 60.25%
|
|
|
Peregrine Asset Advisers, Inc.
Portland, OR |
Nov 04, 2024 Q3 2024 |
10,000
shares
|
$8,900
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
8,924
shares
|
$7,942
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
8,828
shares
|
$7,856
0.0% of portfolio
|
Q3 2024
Reduced 52.23%
|
|
|
Group One Trading, L.P.
Chicago, IL |
Nov 14, 2024 Q3 2024 |
4,911
shares
|
$4,370
0.0% of portfolio
|
Q3 2024
Reduced 71.05%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 13, 2024 Q3 2024 |
900
shares
|
$801
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Bollard Group LLC
Boston, MA |
Nov 13, 2024 Q3 2024 |
712
shares
|
$633
0.0% of portfolio
|
Q3 2020
Reduced 75.93%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
281
shares
|
$250
0.0% of portfolio
|
Q4 2023
Reduced 83.76%
|
|
|
Raleigh Capital Management Inc.
Cary, NC |
Oct 21, 2024 Q3 2024 |
250
shares
|
$222
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
238
shares
|
$211
0.0% of portfolio
|
Q3 2024
Reduced 98.6%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
117
shares
|
$104
0.0% of portfolio
|
Q2 2024
Reduced 97.33%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|